Post-reconstruction dermatitis of the breast Journal Article


Authors: Rosen, A. C.; Goh, C.; Lacouture, M. E.; Mehrara, B. J.; Cordeiro, P. G.; Myskowski, P. L.
Article Title: Post-reconstruction dermatitis of the breast
Abstract: Background Approximately one-third of women diagnosed with breast cancer undergo mastectomy with subsequent implant-based or autogenous tissue-based reconstruction. Potential complications include infection, capsular contracture, and leak or rupture of implants with necessity for explantation. Skin rashes are infrequently described complications of patients who undergo mastectomy with or without reconstruction. Methods A retrospective analysis of breast cancer patients referred to the Dermatology Service for diagnosis and management of a rash post-mastectomy and expander or implant placement or transverse rectus abdominis myocutaneous (TRAM) flap reconstruction was performed. Parameters studied included reconstruction types, time to onset, clinical presentation, associated symptoms, results of microbiologic studies, management, and outcome. Results We describe 21 patients who developed a rash on the skin overlying a breast reconstruction. Average time to onset was 25.7 months after expander placement or TRAM flap reconstruction. Clinical presentations included macules and papules or scaly, erythematous patches and plaques. Five patients had cultures of the rash, which were all negative. Skin biopsy was relatively contraindicated in areas of skin tension, and was reserved for non-responding eruptions. Treatments included topical corticosteroids and topical antibiotics, which resulted in complete or partial responses in all patients with documented follow-ups. Conclusion Our findings suggest that tension and post-surgical factors play a causal role in this hitherto undescribed entity: “post-reconstruction dermatitis of the breast.” This is a manageable condition that develops weeks to years following breast reconstruction. Topical corticosteroids and antibiotics result in restoration of skin barrier integrity and decreased secondary infection. © 2017 British Association of Plastic, Reconstructive and Aesthetic Surgeons
Keywords: adult; clinical article; human tissue; treatment outcome; treatment response; aged; middle aged; retrospective studies; surgical flaps; united states; skin manifestation; follow up; breast cancer; skin biopsy; mastectomy; administration, topical; steroid; breast neoplasms; breast reconstruction; mammaplasty; retrospective study; risk factor; rash; postoperative complication; postoperative complications; symptom; antiinfective agent; anti-bacterial agents; conservative treatment; erythema; hyperpigmentation; glucocorticoid; papule; dermatitis; hydrocortisone; ketoconazole; transverse rectus abdominis musculocutaneous flap; microbiological examination; pseudomonic acid; sodium chloride; breast augmentation; liposarcoma; glucocorticoids; triamcinolone; adverse effects; breast implantation; fluocinonide; clinical outcome; silicone; procedures; betamethasone dipropionate; topical drug administration; eczema; humans; human; female; priority journal; article; topical corticosteroids; xeroderma; polysporin; breast dermatitis; postinflammatory hyperpigmentation; skin tension
Journal Title: Journal of Plastic Reconstructive and Aesthetic Surgery
Volume: 70
Issue: 10
ISSN: 1748-6815
Publisher: Elsevier Science, Inc.  
Date Published: 2017-10-01
Start Page: 1369
End Page: 1376
Language: English
DOI: 10.1016/j.bjps.2017.05.012
PUBMED: 28602267
PROVIDER: scopus
PMCID: PMC5667645
DOI/URL:
Notes: Article -- Export Date: 2 January 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mario E Lacouture
    457 Lacouture
  2. Babak Mehrara
    448 Mehrara
  3. Peter G Cordeiro
    282 Cordeiro
  4. Patricia Myskowski
    216 Myskowski